₹ 6.3 Cr
Volume Transacted
(Dec 26, 2024)
34.5 K
Stocks Traded
(Dec 26, 2024)
Last Updated on: Dec 26, 2024
Gland Pharma Ltd
NSE: GLAND
Market Cap
₹ 29324.16 crore
Last updated on: Dec 24, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Historical Market Cap of Gland Pharma Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
No data available
* All values are in ₹ crore
No data available
* All values are consolidated
Last Updated time:
Gland Pharma Ltd
NSE: GLAND
Share Price
₹ 1825.5
45.60 (2.56%)
Last updated on: Dec 26, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
24 Dec 2024 | 1779.9 | 1745.1 | 1807 | 1745.1 |
23 Dec 2024 | 1766.05 | 1805.15 | 1805.15 | 1746 |
20 Dec 2024 | 1769.75 | 1770.05 | 1794 | 1764.8 |
19 Dec 2024 | 1775.8 | 1755.05 | 1790.7 | 1750 |
18 Dec 2024 | 1763.9 | 1742.05 | 1783.15 | 1742.05 |
17 Dec 2024 | 1751.05 | 1739.95 | 1779.35 | 1725 |
16 Dec 2024 | 1731.3 | 1733.8 | 1753.85 | 1726.9 |
13 Dec 2024 | 1748.2 | 1769.95 | 1769.95 | 1737.65 |
12 Dec 2024 | 1778.6 | 1855.25 | 1860 | 1764.5 |
11 Dec 2024 | 1775.35 | 1762.05 | 1787.1 | 1755.7 |
Date | Price (₹) |
---|---|
24 Dec 2024 | 1779.9 |
23 Dec 2024 | 1766.05 |
20 Dec 2024 | 1769.75 |
19 Dec 2024 | 1775.8 |
18 Dec 2024 | 1763.9 |
17 Dec 2024 | 1751.05 |
16 Dec 2024 | 1731.3 |
13 Dec 2024 | 1748.2 |
12 Dec 2024 | 1778.6 |
11 Dec 2024 | 1775.35 |
Strength
2
S
Weakness
1
W
Opportunity
0
O
Threats
0
T
Revenue
Profitability
Affordability
Liquidity
Dividend
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
No data available
No data available
No data available
No data available
Historical P/E Ratio of Gland Pharma Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
No data available
* All values are in %
Historical Revenue of Gland Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical EBITDA of Gland Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
No data available
* All values are in ₹ crore
Historical Net Profit of Gland Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Gland Pharma Ltd
NSE: GLAND
DIVIDENDPAYOUT
₹ 20
Last updated on: Aug 16, 2024
Gland Pharma subsidiary receives 10 observations from French drug regulator ANSM
In a regulatory filing made yesterday, the company stated that the Agence nationale de s'c...
26 Dec 2024 09:36
Gland Pharma rises on USFDA nod for vitamin-K deficiency drug
The product is bioequivalent and therapeutically equivalent to the reference listed drug (...
12 Dec 2024 10:06
Gland Pharma receives USFDA approval for Phytonadione Injectable Emulsion
Gland Pharma has received approval from the United States Food and Drug Administration (US...
11 Dec 2024 18:20
Gland Pharma rises on USFDA nod for ophthalmic solution
The approved drug is bioequivalent and therapeutically equivalent to the reference listed ...
03 Dec 2024 11:05
Gland Pharma Ltd spurts 1.67%, rises for third straight session
Gland Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 1809....
03 Dec 2024 13:06
Gland Pharma soars as Q2 PAT rises 9% QoQ to Rs 282 cr
On a consolidated basis, the firm's net profit declined 15.74% to Rs 163.53 crore despite ...
05 Nov 2024 10:42
Unlimited trading starting at just Rs. 249*